Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116721 | SCV000150694 | uncertain significance | not provided | 2013-08-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000186613 | SCV000167728 | benign | not specified | 2013-11-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000186613 | SCV000337466 | benign | not specified | 2018-03-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082699 | SCV000563061 | benign | Autosomal dominant nocturnal frontal lobe epilepsy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313868 | SCV000847859 | likely benign | Inborn genetic diseases | 2016-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |